Current
21.9×
5-Year Average
28.3×
All-Time High
71.7×
All-Time Low
10.8×
P/E Ratio daily chart for Medtronic (MDT)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/E Ratio for Medtronic (MDT) from 2002 to 2026
| 2026 | $106.80B | $4.80B | 22.2× | — | |
| 2025 | — | $4.66B | — | — | |
| 2024 | — | $3.68B | — | — | |
| 2023 | $120.64B | $3.76B | 32.1× | +4.4× | |
| 2022 | $139.59B | $5.04B | 27.7× | -21.2× | |
| 2021 | $176.39B | $3.61B | 48.9× | +21.6× | |
| 2020 | $130.88B | $4.79B | 27.3× | +1.6× | |
| 2019 | $119.06B | $4.63B | 25.7× | -9.3× | |
| 2018 | $108.57B | $3.10B | 35.0× | +6.5× | |
| 2017 | $114.64B | $4.03B | 28.5× | -2.9× | |
| 2016 | $110.87B | $3.54B | 31.3× | -8.3× | |
| 2015 | $105.89B | $2.67B | 39.6× | +20.4× | |
| 2014 | $58.82B | $3.06B | 19.2× | +5.5× | |
| 2013 | $47.34B | $3.47B | 13.7× | +2.7× | |
| 2012 | $39.73B | $3.62B | 11.0× | -3.5× | |
| 2011 | $44.68B | $3.10B | 14.4× | -1.1× | |
| 2010 | $48.07B | $3.10B | 15.5× | -1.5× | |
| 2009 | $35.68B | $2.10B | 17.0× | -7.5× | |
| 2008 | $54.72B | $2.23B | 24.5× | +2.9× | |
| 2007 | $60.68B | $2.80B | 21.7× | -1.7× | |
| 2006 | $59.43B | $2.55B | 23.3× | -12.0× | |
| 2005 | $63.67B | $1.80B | 35.3× | +4.1× | |
| 2004 | $61.08B | $1.96B | 31.2× | -5.2× | |
| 2003 | $58.17B | $1.60B | 36.4× | -18.7× | |
| 2002 | $54.18B | $984.00M | 55.1× | — |
- 202622.2×
- 2025—
- 2024—
- 202332.1×
- 202227.7×
- 202148.9×
- 202027.3×
- 201925.7×
- 201835.0×
- 201728.5×
- 201631.3×
- 201539.6×
- 201419.2×
- 201313.7×
- 201211.0×
- 201114.4×
- 201015.5×
- 200917.0×
- 200824.5×
- 200721.7×
- 200623.3×
- 200535.3×
- 200431.2×
- 200336.4×
- 200255.1×
About P/E Ratio at Medtronic (MDT)
Medtronic (MDT) P/E ratio is 21.9× as of June 5, 2026. The 5-year average is 28.3×. The sector median currently stands at 25.0×. The current ratio is at the 5th percentile of its own 10-year history.
Medtronic (MDT) historical P/E ratio has ranged from a low of 10.8× (2011) to a high of 71.7× (2002) in the available daily series.
The price-to-earnings (P/E) ratio, also called the earnings multiple, measures how much investors pay per dollar of a company's trailing twelve-month (TTM) earnings. It is calculated as share price ÷ TTM diluted EPS (equivalent to market capitalisation ÷ TTM net income). A higher P/E implies the market is pricing in stronger future earnings growth or lower risk; a lower P/E can signal slower expected growth, higher risk, or potential undervaluation.
Medtronic P/E Ratio by Year
Medtronic P/E Ratio 2026: 22.2×
Medtronic (MDT) P/E ratio in 2026 was 22.2×, contracted from 32.1× the prior year.
Medtronic P/E Ratio 2023: 32.1×
Medtronic (MDT) P/E ratio in 2023 was 32.1×, expanded from 27.7× the prior year.
Medtronic P/E Ratio 2022: 27.7×
Medtronic (MDT) P/E ratio in 2022 was 27.7×, contracted from 48.9× the prior year.
Medtronic P/E Ratio 2021: 48.9×
Medtronic (MDT) P/E ratio in 2021 was 48.9×, expanded from 27.3× the prior year.
Medtronic P/E Ratio 2020: 27.3×
Medtronic (MDT) P/E ratio in 2020 was 27.3×.
Sector peers by P/E Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/E Ratio — table
Healthcare peers of Medtronic (MDT), ranked by P/E ratio.
| 23.1× | |
| 22.2× | |
| 21.7× | |
| 21.6× | |
| 21.6× | |
| 21.1× | |
| 21.1× | |
| 21.0× | |
| 20.9× | |
| 20.7× | |
| 20.4× | |
| 19.7× | |
| 18.9× | |
| 18.8× | |
| 18.5× | |
| 18.2× | |
| 17.0× | |
| 15.8× | |
| 13.3× | |
| 13.1× | |
| 12.3× | |
| 11.1× | |
| 8.6× | |
| 7.9× | |
| 7.2× |
- 22.2×
- 21.7×
- 21.6×
- 21.6×
- 21.1×
- 21.0×
- 20.9×
- 20.7×
- 19.7×
- 18.9×
- 18.5×
- 15.8×
- 13.3×
- 13.1×
- 11.1×
- 7.9×
Frequently asked questions
Medtronic (MDT) Key Financials
Charts, filings, and peer comparison for every metric